Allo-HLA reactivity of virus-specific memory T cells is common
Top Cited Papers
Open Access
- 15 April 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 115 (15) , 3146-3157
- https://doi.org/10.1182/blood-2009-07-234906
Abstract
Graft-versus-host disease and graft rejection are major complications of allogeneic HLA-mismatched stem cell transplantation or organ transplantation that are caused by alloreactive T cells. Because a range of acute viral infections have been linked to initiating these complications, we hypothesized that the cross-reactive potential of virus-specific memory T cells to allogeneic (allo) HLA molecules may be able to mediate these complications. To analyze the allo-HLA reactivity, T cells specific for Epstein-Barr virus, cytomegalovirus, varicella zoster virus, and influenza virus were tested against a panel of HLA-typed target cells, and target cells transduced with single HLA molecules. Eighty percent of T-cell lines and 45% of virus-specific T-cell clones were shown to cross-react against allo-HLA molecules. The cross-reactivity of the CD8 and CD4 T-cell clones was directed primarily against HLA class I and II, respectively. However, a restricted number of CD8 T cells exhibited cross-reactivity to HLA class II. T-cell receptor (TCR) gene transfer confirmed that allo-HLA reactivity and virus specificity were mediated via the same TCR. These results demonstrate that a substantial proportion of virus-specific T cells exert allo-HLA reactivity, which may have important clinical implications in transplantation settings as well as adoptive transfer of third-party virus-specific T cells.Keywords
This publication has 44 references indexed in Scilit:
- Contribution of Naïve and Memory T-Cell Populations to the Human Alloimmune ResponseAmerican Journal of Transplantation, 2009
- Cutting Edge: Highly Alloreactive Dual TCR T Cells Play a Dominant Role in Graft-versus-Host DiseaseThe Journal of Immunology, 2009
- Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trialBlood, 2007
- Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexesNature Immunology, 2007
- αβ T-Cell Receptor Engineered γδ T Cells Mediate Effective Antileukemic ReactivityCancer Research, 2006
- Primary Allogeneic T-Cell Responses against Mantle Cell Lymphoma Antigen-Presenting Cells for Adoptive Immunotherapy after Stem Cell TransplantationClinical Cancer Research, 2005
- The Single Antigen expressing Lines (SALs) Concept: An Excellent Tool for Screening for HLA-Specific AntibodiesHuman Immunology, 2005
- Signaling control of memory T cell generation and functionSeminars in Immunology, 2004
- Analyzing t-cell responses to cytomegalovirus by cytokine flow cytometryHuman Immunology, 2004
- Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.The Journal of Experimental Medicine, 1975